Clinical trial design issues in schizophrenic research

Daniel Casey

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Research studies are an indispensable tool in the Food and Drug Administration approval process. Becoming familiar with different research study designs helps one to understand and interpret the results of clinical trials. Research studies are undertaken with 2 major goals in mind: (1) to get a drug into registration (regulatory needs) and (2) to understand the clinical application of medicines (clinical application needs). This article discusses the 2 major goals of research studies, the design issues associated with those goals, and the design features of several recent comparative studies of atypical antipsychotics.

Original languageEnglish (US)
Pages (from-to)17-22
Number of pages6
JournalJournal of Clinical Psychiatry
Volume62
Issue numberSUPPL. 9
StatePublished - 2001
Externally publishedYes

Fingerprint

Research Design
Clinical Trials
Drug Approval
Clinical Medicine
United States Food and Drug Administration
Research
Antipsychotic Agents
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Clinical Psychology

Cite this

Clinical trial design issues in schizophrenic research. / Casey, Daniel.

In: Journal of Clinical Psychiatry, Vol. 62, No. SUPPL. 9, 2001, p. 17-22.

Research output: Contribution to journalArticle

Casey, Daniel. / Clinical trial design issues in schizophrenic research. In: Journal of Clinical Psychiatry. 2001 ; Vol. 62, No. SUPPL. 9. pp. 17-22.
@article{fb745de4d2524ead9a142af2a0a069c6,
title = "Clinical trial design issues in schizophrenic research",
abstract = "Research studies are an indispensable tool in the Food and Drug Administration approval process. Becoming familiar with different research study designs helps one to understand and interpret the results of clinical trials. Research studies are undertaken with 2 major goals in mind: (1) to get a drug into registration (regulatory needs) and (2) to understand the clinical application of medicines (clinical application needs). This article discusses the 2 major goals of research studies, the design issues associated with those goals, and the design features of several recent comparative studies of atypical antipsychotics.",
author = "Daniel Casey",
year = "2001",
language = "English (US)",
volume = "62",
pages = "17--22",
journal = "Journal of Clinical Psychiatry",
issn = "0160-6689",
publisher = "Physicians Postgraduate Press Inc.",
number = "SUPPL. 9",

}

TY - JOUR

T1 - Clinical trial design issues in schizophrenic research

AU - Casey, Daniel

PY - 2001

Y1 - 2001

N2 - Research studies are an indispensable tool in the Food and Drug Administration approval process. Becoming familiar with different research study designs helps one to understand and interpret the results of clinical trials. Research studies are undertaken with 2 major goals in mind: (1) to get a drug into registration (regulatory needs) and (2) to understand the clinical application of medicines (clinical application needs). This article discusses the 2 major goals of research studies, the design issues associated with those goals, and the design features of several recent comparative studies of atypical antipsychotics.

AB - Research studies are an indispensable tool in the Food and Drug Administration approval process. Becoming familiar with different research study designs helps one to understand and interpret the results of clinical trials. Research studies are undertaken with 2 major goals in mind: (1) to get a drug into registration (regulatory needs) and (2) to understand the clinical application of medicines (clinical application needs). This article discusses the 2 major goals of research studies, the design issues associated with those goals, and the design features of several recent comparative studies of atypical antipsychotics.

UR - http://www.scopus.com/inward/record.url?scp=0035018112&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035018112&partnerID=8YFLogxK

M3 - Article

C2 - 11379826

AN - SCOPUS:0035018112

VL - 62

SP - 17

EP - 22

JO - Journal of Clinical Psychiatry

JF - Journal of Clinical Psychiatry

SN - 0160-6689

IS - SUPPL. 9

ER -